Physician

John S Antalis, M.D.

According to 2025 Medicare claims, John Antalis, M.D. (NPI: 1265420731) practices family practice in the Dalton, GA market, with the plurality of this provider's patient population coming from Whitfield, GA. This provider's primary affiliated billing organization is SOUTHEAST MEDICAL GROUP, P.C. (NPI: 1235296054; TIN: 581896468) and primary practice location at 30720-8394. Antalis is affiliated with the Physician Partners ACO 2, LLC/Select Physicians Associates ACO (ACO ID: A5308) and Southeast Quality Network, LLC (ACO ID: A5337), participating under the MSSP model.

Antalis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 298 traditional Medicare patients, billed 3,177 HCPCS/CPT codes, and received $96,756 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,181 prescription claims across 326 beneficiaries totaling $349,666 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 33 claims. Open Payments data shows 12 records totaling $298. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $288,019 to $96,756. Similarly, Part D prescription costs have fallen sharply in recent years, from $706,857 to $349,666. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $37,712 to $13,559.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	725	16,271	$288,019
2016	713	15,489	$277,295
2017	599	14,321	$255,056
2018	657	14,449	$244,613
2019	533	13,387	$216,990
2020	547	10,799	$169,161
2021	563	9,637	$160,260
2022	378	8,742	$147,354
2023	256	2,398	$52,368
2024	298	3,177	$96,756

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	707	15,098	$706,857
2016	758	14,268	$736,261
2017	726	13,352	$719,280
2018	709	12,002	$646,350
2019	697	10,865	$655,106
2020	852	11,552	$705,180
2021	751	10,792	$679,348
2022	663	9,731	$616,877
2023	511	3,845	$266,070
2024	326	4,181	$349,666

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	114	567	$34,462
2016	63	359	$17,492
2017	66	324	$16,579
2018	100	358	$6,902
2019	74	382	$9,579
2020	44	267	$6,902
2021	41	265	$9,716
2022	15	181	$11,292
2023	N/R	181	$13,616
2024	N/R	33	$9,712

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	104	104	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	219	435	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	125	258	$59
G0444	Annual depression screening, 5 to 15 minutes	91	91	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	184	457	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	60	1,738	$63,651
Ozempic	Semaglutide	46	1,358	$42,947
Farxiga	Dapagliflozin Propanediol	39	1,710	$32,028
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	750	$16,423
Eliquis	Apixaban	25	750	$14,124

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	22	$9,596
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	11	$116

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$298	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John S. Antalis, M.D.?

Tedicare shows public-source Medicare data for John S. Antalis, M.D. (NPI 1265420731), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John S. Antalis, M.D. have ACO affiliation data?

John S. Antalis, M.D. is shown with ACO affiliation data for Physician Partners ACO 2, LLC/Select Physicians Associates ACO (MSSP, ACO ID A5308) and Southeast Quality Network, LLC (MSSP, ACO ID A5337).

What billing organization is linked to John S. Antalis, M.D.?

John S. Antalis, M.D. is linked to SOUTHEAST MEDICAL GROUP, P.C. (billing NPI 1235296054) in the available physician profile data.

Does John S. Antalis, M.D. have Open Payments data?

John S. Antalis, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.